• Fiscal Year end for Oramed Pharmaceuticals Inc falls in the month of December .

    All items in Millions except EPS data.

    12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Sales 1 3 1 3 3
    Cost Of Goods 0 0 0 0 0
    Gross Profit 1 3 1 3 3
    Selling & Adminstrative & Depr. & Amort Expenses 17 43 13 27 14
    Income After Depreciation & Amortization -16 -41 -12 -24 -12
    Non-Operating Income 23 4 0 1 1
    Interest Expense 2 1 0 0 0
    Pretax Income 5 -38 -12 -23 -12
    Income Taxes 0 0 0 0 0
    Minority Interest 0 -1 -1 -1 0
    Investment Gains/Losses 0 0 0 0 0
    Other Income/Charges 0 0 0 0 0
    Income From Cont. Operations 5 -38 -12 -23 -12
    Extras & Discontinued Operations 0 0 0 0 0
    Net Income (GAAP) 6 -37 -12 -22 -12
    Depreciation Footnote 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Income Before Depreciation & Amortization -16 -41 -12 -24 -12
    Depreciation & Amortization (Cash Flow) 0 0 0 0 0
    Income After Depreciation & Amortization -16 -41 -12 -24 -12
    Earnings Per Share Data 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Average Shares 40.57 39.00 28.47 20.53 17.46
    Diluted EPS Before Non-Recurring Items -0.27 -0.94 -0.78 -0.56 0.82
    Diluted Net EPS (GAAP) 0.14 -0.94 -0.78 -0.78 -0.56

    Fiscal Year end for Oramed Pharmaceuticals Inc falls in the month of December .

    All items in Millions except EPS data.

    9/30/24 6/30/24 3/31/24 12/31/23 9/30/23
    Sales 0.00 0.00 0.00 0.00 0.00
    Cost Of Goods 0.00 0.00 0.00 0.00 0.00
    Gross Profit 0.00 0.00 0.00 0.00 0.00
    SG&A, R&D, and Dept/Amort Expenses 3.09 3.13 2.96 3.88 2.90
    Income After SG&A, R&D, and Dept/Amort Expenses -3.09 -3.13 -2.96 -3.88 -2.90
    Non-Operating Income -15.42 14.23 5.09 18.38 0.44
    Interest Expense 0.00 0.26 0.59 1.21 0.83
    Pretax Income -18.51 10.84 1.53 13.30 -3.28
    Income Taxes 1.13 1.63 0.00 0.00 0.00
    Minority Interest -0.02 -0.01 0.00 -0.26 -0.06
    Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
    Other Income/Charges 0.00 0.00 0.00 0.00 0.00
    Income From Cont. Operations -19.64 9.20 1.53 13.30 -3.28
    Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
    Income (GAAP) -19.62 9.21 1.53 13.55 -3.22
    Earnings Per Share Data 9/30/24 6/30/24 3/31/24 12/31/23 9/30/23
    Average Shares 40.90 41.59 41.56 40.41 40.45
    Diluted EPS Before Non-Recurring Items -0.48 0.22 0.04 -0.08 -0.08
    Diluted Net EPS (GAAP) -0.48 0.22 0.04 0.33 -0.08